Table 5 Possible pathways underlying growth–breast cancer associations (adapted from Okasha et al., 2002)
Growth as a biomarker for other exposures that influence breast cancer risk |
1. In utero exposures |
Foetal nutrition is influenced by maternal steroids with greater exposure resulting in greater foetal growth |
Exposure to maternal steroids during breast development in utero may increase cancer risk |
2. Infections |
Chronic infection may stunt growth – in particular trunk length |
Absence of childhood infection may make individuals susceptible to infections, which if acquired in later life are associated with cancer risk and may result in an underdeveloped immune function |
3. Calorie intake |
Lower calorie intake in childhood results in shorter stature and in particular shorter leg length |
Lower incidence of cancer in rats fed a calorie-restricted diet |
Childhood calorie intake may be related to adult cancer |
Calorie intake may also influence growth-promoting hormones (see below) |
Growth as a biomarker for biological mediators of risk |
4. Cellularity |
Greater trunk length may reflect a larger number of breast cells |
A larger number of cells increases the risk that one will undergo malignant transformation |
5. Growth-promoting hormones |
IGF is related to growth, particularly leg length |
IGF is affected by nutritional intake during childhood |
IGF is associated with cancer in animal studies although results from epidemiological studies are inconsistent |
6. Oestrogen |
Low lifetime exposure to oestrogen will result in shorter trunk length because of osteoporotic collapse |
Later age at menarche will result in greater leg length and total height and may be associated with reduced lifetime exposure to oestrogen |
Breast cancer risk is associated with increased exposure to oestrogen |